Dr. Grace Shumaker
Claim this profileUniversity of Mississippi Medical Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
1 drug studied
Area of expertise
1Lung Cancer
Stage III
Stage I
Stage II
2Non-Small Cell Lung Cancer
Stage III
Stage I
Stage II
Affiliated Hospitals
University Of Mississippi Medical Center
More about Grace Shumaker
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Grace Shumaker has experience with
- Durvalumab
Breakdown of trials Grace Shumaker has run
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Grace Shumaker specialize in?
Grace Shumaker focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage I.
Is Grace Shumaker currently recruiting for clinical trials?
No, Grace Shumaker is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Grace Shumaker has studied deeply?
Yes, Grace Shumaker has studied treatments such as Durvalumab.
What is the best way to schedule an appointment with Grace Shumaker?
Apply for one of the trials that Grace Shumaker is conducting.
What is the office address of Grace Shumaker?
The office of Grace Shumaker is located at: University of Mississippi Medical Center, Jackson, Mississippi 39216 United States. This is the address for their practice at the University of Mississippi Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.